Who is sponsoring NCT03242135?

NCT03242135 is sponsored by Assiut University.

What condition does NCT03242135 study?

NCT03242135 studies Predicting Liver Cell Failure & Portal Hypertension in LC.

Is NCT03242135 still recruiting?

NCT03242135 is currently status unknown. Last updated 8 August 2017.

Last reviewed 2017-08-08 · How we verify

NCT03242135: RDW

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of RDW as Anon Invasive Index for Predicting Liver Cell Failure and Portal Hypertension in Cirrhotic Patient

Status unknown Last updated 8 August 2017

What this trial tests

trial in Predicting Liver Cell Failure & Portal Hypertension in LC in 100 participants. Status unknown.

Timeline

21 September 2016

Primary endpoint
21 February 2018

30 December 2018

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	21 September 2016
Primary completion	21 February 2018
Estimated completion	30 December 2018
Sites	1 location across Egypt

Conditions studied

Predicting Liver Cell Failure & Portal Hypertension in LC — all drugs for Predicting Liver Cell Failure & Portal Hypertension in LC →

Sponsor

Assiut University

Who can join

Adults 17 to 90, any sex, with Predicting Liver Cell Failure & Portal Hypertension in LC. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

role of RDW as anon invasive method for predicting liver cell failure \& portal hypertension in cirrhotic patient

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03242135 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 8 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03242135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing